Journal profile · Multiple

Kidney Cancer

ISSN 2468-4562 · eISSN 2468-4570 · SAGE Publications (formerly IOS Press) · Netherlands

Kidney Cancer: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.4 (journal website); fully open access; APC about USD 2,800; review about 16 weeks (community reports); 9 articles in 2025; indexed in ESCI and Scopus.

Impact factor1.4From the journal's website, latest value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review timeabout 16 weeksCommunity average
APCUSD 2,800Fully open access
Acceptance—No reports yet
Articles per year92025 · OpenAlex count

Scope

Aims, scope and focus

Kidney Cancer is published by SAGE Publications (formerly IOS Press) and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Renal cell carcinoma treatment, Renal and related cancers and Cancer Genomics and Diagnostics, together about 68.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Kidney Cancer is an international multidisciplinary journal to facilitate progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pharmacology, ethics, patient advocacy and survivorship, diagnosis and treatment of tumors of the kidney. The journal publishes research reports, reviews, short … | View full journal description

From the journal's Aims & Scope

Research area (LetPub): Multiple

Editor-in-chief Primo N. LaraPublisher website

Editorial board by country: none in mainland China; most named United States 47, Netherlands 5, Spain 4, Brazil 4, United Kingdom 3 (78 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Renal cell carcinoma treatmentMedicine34.1%
  2. Renal and related cancersBiochemistry, Genetics and Molecular Biology20.3%
  3. Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology14%
  4. Cancer Immunotherapy and BiomarkersMedicine5.2%
  5. Bladder and Urothelial Cancer TreatmentsMedicine4.5%
  6. Economic and Financial Impacts of CancerEconomics, Econometrics and Finance2.8%
  7. Pancreatic and Hepatic Oncology ResearchMedicine2.3%
  8. Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance2.2%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOncologyZone 4
MinorUrology & NephrologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOncologyZone 4
MinorUrology & NephrologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

Web of SciencePublisher website

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher)
1.4Publisher website ·
5-year impact factor (publisher)
1Publisher website ·
CiteScore 2026-06
1.7LetPub ·
SJR 2026-06
0.49LetPub ·
SNIP 2026-06
0.39LetPub ·
h-index
15OpenAlex ·
i10-index
34OpenAlex ·
2-year mean citedness
1.41OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
79.17%LetPub ·

Volume

Articles per year
16LetPub ·
Articles per year (publisher)
3Publisher website ·

Articles by year OpenAlex count · 260 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026220
2025993
2024232345
2023151523
2022252563
20212626102

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 16 weeksLetPub ·
Submission to publication (journal-reported)
about 16 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 2,800YesCC BY, CC BY-NC
LetPubEUR 750 / USD 750Yes—
Publisher websiteYes, amount not published——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare4 items from the author guidelines
Abstract
≤ 250 words
Manuscript length
≤ 4,000 words
Reference style
Vancouver
First submission
Free format: the journal's layout is not required
Publisher website · model-extracted, each line checked against the text
Article types accepted14, with length limits
  1. brief reportPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Research Reports Organization and style of presentation: M…Length not stated
  2. commentariesCommentaries: Commentaries can be around 1000 words with an abstract and no other subdivisions.Length not stated
  3. commentaryPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Research Reports Organization and style of presentation: M…main text ≤ 1,000 words
  4. editorialPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Research Reports Organization and style of presentation: M…Length not stated
  5. full articlePlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Research Reports Organization and style of presentation: M…Length not stated
  6. letters to the editorPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Research Reports Organization and style of presentation: M…main text ≤ 1,000 words
  7. research articlePlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Research Reports Organization and style of presentation: M…main text ≤ 4,000 words
  8. research reportPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Research Reports Organization and style of presentation: M…Length not stated
  9. research reportsResearch Reports Organization and style of presentation: Manuscripts must be written in US English.Length not stated
  10. reviewPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Research Reports Organization and style of presentation: M…Length not stated
  11. reviewsReviews: Reviews should be authoritative and topical and provide comprehensive and balanced coverage of a timely and/or controversial issue.Length not stated
  12. short communicationPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Research Reports Organization and style of presentation: M…main text ≤ 1,500 words
  13. short communications/brief reportsShort Communications/Brief Reports: Short Communications and Brief Reports are articles of original scholarship of unusual interest of less than 1500 words (not…Length not stated
  14. systematic reviewPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Research Reports Organization and style of presentation: M…Length not stated
Publisher website
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
Authorship Author contributions

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.

Source ↗Publisher website ·
Data availability Data availability

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

Source ↗Publisher website ·
Publication ethics Ethical considerations

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

Source ↗Publisher website ·
Open access Publishing fees and open access

There are no fees payable to submit or publish in this journal. Figures supplied in colour will appear in colour online regardless of whether or not these illustrations are reproduced in colour in the printed version. For specifically requested colour reproduction in print, you will receive information regarding the costs from Sage after receipt of your accepted article. Optional open access publi…

Source ↗Publisher website ·
Peer review Peer review policy

Single anonymized peer review Model summary

The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

Source ↗Publisher website ·
Plagiarism Plagiarism

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

Source ↗Publisher website ·
Preprints Preprints

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

Source ↗Publisher website ·
Trial registration / reporting guidelines Clinical trial registration

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
SAGE Publications (formerly IOS Press)
Country or region
Netherlands
Language
English
ISSN
2468-4562
Electronic ISSN
2468-4570
Official links

FAQ

Frequently asked questions about Kidney Cancer

What CAS zone is Kidney Cancer in?

In the 2025 upgraded edition of the CAS Journal Ranking, Kidney Cancer is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology / Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Kidney Cancer?

The journal's website gives an impact factor of 1.4; this is the journal's own figure, as LetPub lists none for it; CiteScore 1.7, h-index 15.

How long does peer review take at Kidney Cancer?

Authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Kidney Cancer?

According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 4,000 words; Reference style: Vancouver; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Kidney Cancer based?

Of the 78 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (47), Netherlands (5) and Spain (4). Counted from the institutions listed on the board page; for reference only.

Which databases index Kidney Cancer?

According to LetPub and DOAJ records, Kidney Cancer is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science; that list has not been checked against each database.

Is Kidney Cancer open access, and what is the APC?

Kidney Cancer is a fully open-access journal. APC about USD 2,800.

Sources and updates

The facts on this page come from LetPub, DOAJ, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .